AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MetaVia Inc. Director's Dealing 2019

Jul 26, 2019

34919_dirs_2019-07-26_49e65870-56f5-4c62-b553-994bcf2e72da.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemphire Therapeutics Inc. (GEMP)
CIK: 0001638287
Period of Report: 2019-07-24

Reporting Person: KOUSKY KENNETH W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-24	Common Stock	A	15000	—	Acquired	26935	Direct

Footnotes

F1: 4,472 shares previously held by the BWA Gemphire Investment Group, LLC, and 6,463 shares previously held by BWA Gemphire Investment Group II, LLC were transferred to Mr. Kousky and are now held directly.